Flu drugs show promise against cognitive decline

Article excerpt

A Northwestern University study found that antiviral flu medications may slow cognitive decline and premature aging in people with chronic viral infections, including HIV. Researchers began with blood samples from HIV patients and moved into preclinical drug trials, discovering a potential new therapeutic pathway for cognitive problems in this population. The findings could extend beyond HIV to other age-related conditions like dementia, suggesting a class of existing drugs might be repurposed to address neurological deterioration.